Cellular Therapy Shows Promise for COVID-Related MIS-C in Kids Cellular Therapy Shows Promise for COVID-Related MIS-C in Kids

Two children severely ill with COVID-19-related multisystem inflammatory syndrome showed significant improvement within 24 hours of receiving remestemcel-L, an investigational cellular therapy.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Pediatrics News Source Type: news